How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention.
about
Conceptualizing a Human Right to Prevention in Global HIV/AIDS PolicyStakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as preventionEnsuring Access to HIV Prevention Services in South African HIV Vaccine Trials: Correspondence Between Guidelines and Practices.Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.It's Time: The Case for PrEP as an Active Comparator in HIV Biomedical Prevention Trials.Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?Ethics of ARV based prevention: treatment-as-prevention and PrEP.Evidence of efficacy and human right to health.The devil in the details: thorough assessment of evidence and ethics is needed in evaluating new HIV prevention methods.Ethics in HIV prevention research: clarifying the complexities.
P2860
Q30424601-BF1327C0-5E89-4A1C-995C-C3C6EFD90E00Q30584402-706A18C7-E322-4739-992A-CB9C4DE8CF27Q33783865-4360C038-B7A9-4ADF-887F-D70ED114EB1DQ33854562-B7A211AF-F24C-4DF2-B6E1-1535CBEC29D9Q33897754-57D6BB62-1A1B-4289-B226-56C35F137922Q34968312-9B02C44A-9E1D-475F-9AA2-605017F26A0BQ35187148-6ACA9877-B197-4B24-967C-BA5C9BE95EC2Q37028167-D140B8C0-4736-4C0C-B3CA-D46DF89550A3Q39157699-D5ED6FB8-681C-4BC8-865B-771B6AE9F904Q43715712-3CA28004-B1B7-4619-9D87-E3DBF4D438C8Q46372939-3F24E90A-7074-4176-B9B7-BDE4DBF1289BQ48435062-25923398-E8F6-4A04-ACA0-8DB774357C5CQ48435069-C77E3D43-0AE8-43AE-A67B-60A4CDF7B918Q48435076-BD18F949-B49F-4B63-A35F-DB6F0A07EC91
P2860
How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
How good is "good enough"? The ...... terventions in HIV prevention.
@en
How good is "good enough"? The ...... terventions in HIV prevention.
@nl
type
label
How good is "good enough"? The ...... terventions in HIV prevention.
@en
How good is "good enough"? The ...... terventions in HIV prevention.
@nl
prefLabel
How good is "good enough"? The ...... terventions in HIV prevention.
@en
How good is "good enough"? The ...... terventions in HIV prevention.
@nl
P2093
P2860
P1476
How good is "good enough"? The ...... terventions in HIV prevention.
@en
P2093
Bridget Haire
Christopher F C Jordens
John Kaldor
P2860
P356
10.1080/15265161.2012.671887
P577
2012-01-01T00:00:00Z